Six months of chemotherapy in low-risk stage 3 colorectal cancer patients increases neuropathy compared to three months. IDEA collaboration found similar survival outcomes between three and six months ...

Colorectal Surgeon Dr. Julio Garcia-Aguilar, MD, PhD (seated) with nurse Kieran Kelleher BSN-RN. Dr. Garcia-Aguilar and the colorectal service at MSK are experts at the watch and wait approach to ...

Finding out you have colorectal cancer can feel overwhelming, but you are not alone. Turn to your healthcare team to guide you through treatment and recovery. One common and effective treatment is ...

The investigators provide a long-term follow-up report of EORTC 22921, which examined the addition of preoperative or postoperative chemotherapy to preoperative radiation therapy in patients with ...

An analysis of previous studies shows that waiting longer before beginning chemotherapy after colorectal cancer surgery is associated with lower survival rates, according to the study in the Journal ...

A new AI tool is revolutionizing cancer treatment decisions by analyzing tissue images to predict tumor aggressiveness. This ...

An international research team from the University of Oxford and Nanyang Technological University (NTU Singapore) reports the discovery of a new process for repairing damaged DNA that is particularly ...

Researchers in a recent breakthrough have identified a better and more advanced way to examine cancer biopsies by using ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with ...